Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://carlyhfzj181934.designertoblog.com/70153542/retaglutide-a-promising-glp-1-receptor-agonist